| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 106.241 | 150.116 | - | 98.421 | 44.316 | 37.120 | - | - | - | - |
| Total Income - EUR | 106.241 | 150.118 | - | 98.651 | 46.052 | 37.127 | - | - | - | - |
| Total Expenses - EUR | 106.964 | 149.002 | - | 85.107 | 76.000 | 23.688 | - | - | - | - |
| Gross Profit/Loss - EUR | -722 | 1.116 | - | 13.544 | -29.948 | 13.439 | - | - | - | - |
| Net Profit/Loss - EUR | -722 | 937 | - | 12.559 | -30.404 | 13.330 | - | - | - | - |
| Employees | 3 | 3 | - | 1 | 1 | 1 | - | - | - | - |
Check the financial reports for the company - Eromediks Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 28.903 | 28.608 | - | 27.608 | 10.758 | 10.554 | - | - | - | - |
| Current Assets | 93.890 | 143.456 | - | 96.913 | 107.174 | 110.202 | - | - | - | - |
| Inventories | 48.466 | 100.780 | - | 26.643 | 16.572 | 4.113 | - | - | - | - |
| Receivables | 25.298 | 22.029 | - | 67.741 | 82.530 | 69.950 | - | - | - | - |
| Cash | 20.126 | 20.647 | - | 2.528 | 8.072 | 36.139 | - | - | - | - |
| Shareholders Funds | -35.301 | -34.004 | - | -18.022 | -48.077 | -33.836 | - | - | - | - |
| Social Capital | 45 | 45 | - | 43 | 42 | 41 | - | - | - | - |
| Debts | 158.094 | 206.068 | - | 142.543 | 166.009 | 154.591 | - | - | - | - |
| Income in Advance | 0 | 0 | - | 0 | 0 | 0 | - | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4774 - 4774" | |||||||||
| CAEN Financial Year |
4774
|
|||||||||
Comments - Eromediks Srl